Five Fraction SABR Dose Escalation for Early Stage Squamous Cell Carcinoma of the Lung
Clinical trial NCT03321747 · TERMINATED
Trial details
- NCT number
- NCT03321747
- Sponsor
- Indiana University
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-20
- Primary completion
- 2020-07-09
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.